Azelnidipine is a dihydropyridine calcium channel blocker used in pharmaceutical formulations for the management of hypertension. It is a long-acting calcium channel antagonist that reduces calcium entry into vascular smooth muscle cells, promoting relaxation of blood vessels.
Azelnidipine is a pharmaceutical active ingredient supplied for use in regulated pharmaceutical development and manufacturing, subject to the applicable product specification and regulatory requirements.
SDP provides product information and supports business enquiries for Azelnidipine API, subject to grade availability and batch-specific quality documentation.
Azelnidipine is a synthetic dihydropyridine derivative. Its chemical structure contains a 1,4-dihydropyridine ring, a nitrophenyl group and ester functionalities. It is a lipophilic compound with limited solubility in water.
Azelnidipine is used as an active ingredient in pharmaceutical formulations intended for the management of hypertension. Its use in finished medicinal products must follow the applicable approved formulation, prescribing information and regulatory requirements.
Azelnidipine quality should be evaluated against the approved product specification and applicable regulatory requirements. Depending on the specification, quality testing may include:
The actual acceptance criteria must be confirmed against the batch-specific Certificate of Analysis (COA). Do not claim USP, EP, BP or other pharmacopoeial compliance unless the relevant official monograph and supporting documentation establish it.
Use suitable, tightly closed packaging that protects the material from contamination and inappropriate environmental exposure. Follow the approved supplier specification and SDS for storage temperature, light protection and handling conditions.
Available documentation may include:
Azelnidipine is a dihydropyridine calcium channel blocker used in pharmaceutical products for hypertension management.
The CAS number is 123524-52-7.
Its molecular formula is C₃₃H₃₄N₄O₆.
The molecular weight is approximately 582.65 g/mol.
Azelnidipine is reported to be insoluble in water. Its solubility in organic solvents depends on the solvent and test conditions.
Review the current product specification, batch-specific COA and SDS. Confirm the grade and applicable quality requirements before purchase.
Product Information Disclaimer: This page provides general chemical and product identification information for business enquiry purposes. Confirm the exact grade, approved specification, COA, SDS and regulatory suitability before use.
| Parameter | Specification |
|---|---|
| Appearance | Crystalline solid |
| Identification | IR and HPLC complaint |
| Heavy Metals | NMT 10 ppm |
| Solubility | Insoluble in water |